Haotian Liu1,2, Kai Huang3,4,5, Tao Li6, Tielong Yang1,2, Zhichao Liao1,2, Chao Zhang1,2, Lijie Xiang1,2, Yong Chen3,4, Jilong Yang1,2. 1. Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. 2. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. 3. Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. 4. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 5. Brandon Regional Hospital GME, HCA Healthcare/USF Morsani College of Medicine, Brandon, FL, United States. 6. Department of Bone and Soft-Tissue Tumor, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Abstract
Background: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge. Methods: Desmoid tumor patients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based nomogram was constructed by screening the recurrence-related risk factors using Cox regression analysis. External validation was conducted with data from the Fudan University Shanghai Cancer Center. Results: A total of 385 patients were identified. Finally, after excluding patients without surgery, patients who were lost to follow-up, and patients without complete resection, a total of 267 patients were included in the nomogram construction. Among these patients, 53 experienced recurrence, with a recurrence rate of 20.15%. The 3-year and 5-year recurrence-free survival (RFS) rates were 82.5% and 78%, respectively. Age, tumor diameter, admission status, location, and tumor number were correlated with recurrence in univariate Cox analysis. In multivariate Cox analysis, only age, tumor diameter and tumor number were independent risk factors for recurrence and were then used to construct a web-based nomogram to predict recurrence. The concordance index (C-index) of the nomogram was 0.718, and the areas under the curves (AUCs) of the 3-year and 5-year receiver operating characteristic (ROC) curves were 0.751 and 0.761, respectively. In the external validation set, the C-index was 0.706, and the AUCs of the 3-year and 5-year ROC curves are 0.788 and 0.794, respectively. Conclusions: Age, tumor diameter, and tumor number were independent predictors of recurrence for DTs, and a web-based nomogram containing these three predictors could accurately predict RFS (https://stepforward.shinyapps.io/Desmoidtumor/).
Background: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge. Methods:Desmoid tumorpatients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based nomogram was constructed by screening the recurrence-related risk factors using Cox regression analysis. External validation was conducted with data from the Fudan University Shanghai Cancer Center. Results: A total of 385 patients were identified. Finally, after excluding patients without surgery, patients who were lost to follow-up, and patients without complete resection, a total of 267 patients were included in the nomogram construction. Among these patients, 53 experienced recurrence, with a recurrence rate of 20.15%. The 3-year and 5-year recurrence-free survival (RFS) rates were 82.5% and 78%, respectively. Age, tumor diameter, admission status, location, and tumor number were correlated with recurrence in univariate Cox analysis. In multivariate Cox analysis, only age, tumor diameter and tumor number were independent risk factors for recurrence and were then used to construct a web-based nomogram to predict recurrence. The concordance index (C-index) of the nomogram was 0.718, and the areas under the curves (AUCs) of the 3-year and 5-year receiver operating characteristic (ROC) curves were 0.751 and 0.761, respectively. In the external validation set, the C-index was 0.706, and the AUCs of the 3-year and 5-year ROC curves are 0.788 and 0.794, respectively. Conclusions: Age, tumor diameter, and tumor number were independent predictors of recurrence for DTs, and a web-based nomogram containing these three predictors could accurately predict RFS (https://stepforward.shinyapps.io/Desmoidtumor/).
Authors: Kirsi Santti; Annette Beule; Laura Tuomikoski; Mikko Rönty; Anna-Stina Jääskeläinen; Kauko Saarilahti; Hanna Ihalainen; Maija Tarkkanen; Carl Blomqvist Journal: Strahlenther Onkol Date: 2017-01-02 Impact factor: 3.621
Authors: X D He; Y B Zhang; L Wang; M L Tian; W Liu; Q Qu; B L Li; T Hong; N C Li; Y Q Na Journal: Eur J Surg Oncol Date: 2015-05-13 Impact factor: 4.424
Authors: Veridiana Pires de Camargo; Mary L Keohan; David R D'Adamo; Cristina R Antonescu; Murray F Brennan; Samuel Singer; Linda S Ahn; Robert G Maki Journal: Cancer Date: 2010-05-01 Impact factor: 6.860
Authors: Sam Sedaghat; Maya Sedaghat; Sebastian Krohn; Olav Jansen; Kai Freund; Arne Streitbürger; Benjamin Reichardt Journal: Eur J Radiol Date: 2020-11-12 Impact factor: 3.528
Authors: James E Bates; Christopher G Morris; Nicole M Iovino; Michael Rutenberg; Robert A Zlotecki; C Parker Gibbs; Mark Scarborough; Daniel J Indelicato Journal: Int J Radiat Oncol Biol Phys Date: 2017-12-21 Impact factor: 7.038
Authors: Marco Fiore; Sara Coppola; Amanda J Cannell; Chiara Colombo; Monica M Bertagnolli; Suzanne George; Axel Le Cesne; Rebecca A Gladdy; Paolo G Casali; Carol J Swallow; Alessandro Gronchi; Sylvie Bonvalot; Chandrajit P Raut Journal: Ann Surg Date: 2014-05 Impact factor: 12.969
Authors: Samir Sabharwal; Shivani Ahlawat; Adam S Levin; Christian F Meyer; Eugene Brooks; John Ligon; Carol D Morris Journal: J Surg Oncol Date: 2020-03-24 Impact factor: 3.454
Authors: Milea J M Timbergen; Ron Smits; Dirk J Grünhagen; Cornelis Verhoef; Stefan Sleijfer; Erik A C Wiemer Journal: Front Oncol Date: 2019-05-17 Impact factor: 6.244